VVUS VIVUS, Inc.

1.12
+0.02  (2%)
Previous Close 1.10
Open 1.13
Price To book 6.47
Market Cap 118.36M
Shares 105,682,000
Volume 802,920
Short Ratio 10.69
Av. Daily Volume 728,884

SEC filingsSee all SEC filings

  1. 8-K - Current report 17866928
  2. CT ORDER - Confidential treatment order 17841376
  3. 8-K - Current report 17822228
  4. 8-K - Current report 17809402
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 17809225

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved July 17, 2012.
Qnexa
Obesity
Approved Apr 27 2012. sNDA label change also approved 17 Sept 2014
Avanafil
Erectile dysfunction

SEC Filings

  1. 8-K - Current report 17866928
  2. CT ORDER - Confidential treatment order 17841376
  3. 8-K - Current report 17822228
  4. 8-K - Current report 17809402
  5. 10-Q - Quarterly report [Sections 13 or 15(d)] 17809225
  6. 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] 17784407
  7. CT ORDER - Confidential treatment order 17762221
  8. CT ORDER - Confidential treatment order 17751972
  9. CT ORDER - Confidential treatment order 17745774
  10. 8-K - Current report 17714220